Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Epiminder Extends Stratus Partnership to Support US Minder Launch

EPI: $0.270 -1.82% · MC: $61M

Epiminder has signed a five-year rolling partnership with US neurodiagnostics provider Stratus Neuro, extending an existing agreement supporting its DETECT reimbursement study. Minder’s long-term brain monitoring data will be integrated into the StratusEEG platform to support the study and the commercial launch of the next-generation system. Earlier this month, Epiminder said the US Medicare payment rate for the Minder implant procedure would rise by approximately 13% in 2027.

Source announcements: 2026-11-17 09:16 to 2026-11-17 09:16 Sydney time
Story updated 2026-11-17 12:18 Sydney time
SourcesStrategic partnership with leading US EEG provider
Comments